Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors

Author:

Gendre Pauline1,Mayol Severine2,Mocquard Julie1,Huon Jean‐François13ORCID

Affiliation:

1. CHU Nantes, Pharmacy Department Nantes University Nantes France

2. Faculty of Sociology Nantes University Nantes France

3. INSERM, MethodS in Patients‐centered outcomes and HEalth Research, SPHERE Nantes France

Abstract

AbstractBackgroundClinical pharmacists have a pivotal role in the management of the patient's medication. However, it is necessary to know how pharmacist‐mediated deprescribing could be implemented in a hospital setting according to hospital physicians.ObjectiveTo explore physicians' views on the involvement of hospital pharmacists in the deprescribing process using the example of PPIs.MethodsA qualitative study using two focus groups with hospital physicians was conducted to determine their attitudes regarding deprescribing initiated by the hospital pharmacist. The interviews were recorded and transcribed using the NVivo analysis software. A thematic analysis led to a categorization of all the verbatims.ResultsHospital doctors are reluctant to deprescribe drugs initiated by a colleague and feel that it is the responsibility of the general practitioner (GP), who fails to do so due to lack of time. In this situation, the hospital pharmacist is in the best position to deprescribe because of his/her expertise in drug therapy. This should be a discussion between the hospital pharmacist, the hospital doctor, the GP and the patient. Deprescribing should always be adapted to the patient's context.ConclusionHospital physicians are open to a pharmacist‐mediated, patient‐centred approach to deprescribing as long as the GP is involved.

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Welcome to Basic & Clinical Pharmacology & Toxicology 2024;Basic & Clinical Pharmacology & Toxicology;2023-12-12

2. Advancing deprescribing: Learnings from the first international conference on deprescribing;Basic & Clinical Pharmacology & Toxicology;2023-12-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3